retatrutide parkinson GLP-1 Agonists: A New Frontier in Parkinson’s Treatment? Weight loss drug retatrutide use
Description
What long-term safety data do we have for GLP-1 pills
found that one in eight adults reported having taken a GLP-1 drug
Shi S, Shuang S, Xiangdong L, Guoqiang Z, Feng D, Wenshuang Z, et al
86 In 2014, the drug empagliflozin (EMPA) was approved for the treatment of T2DM
DPP4i: Dipeptidyl peptidase-4 inhibitor
